Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Do analysts recommend HBIO or TMO?

Harvard Bioscience presently has a consensus target price of $2.00, suggesting a potential upside of 390.32%. Thermo Fisher Scientific has a consensus target price of $595.75, suggesting a potential upside of 3.96%. Given Harvard Bioscience's higher possible upside, equities analysts plainly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Thermo Fisher Scientific	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.79

Do institutionals & insiders hold more shares of HBIO or TMO?

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.5% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has better valuation and earnings, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$94.14M	0.19	-$12.40M	-$1.30	-0.31
Thermo Fisher Scientific	$42.88B	5.05	$6.34B	$17.31	33.11

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 15.02% compared to Harvard Bioscience's net margin of -64.68%. Thermo Fisher Scientific's return on equity of 16.97% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-64.68%	-5.64%	-2.15%
Thermo Fisher Scientific	15.02%	16.97%	8.49%

Does the media prefer HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 97 more articles in the media than Harvard Bioscience. MarketBeat recorded 99 mentions for Thermo Fisher Scientific and 2 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 1.89 beat Thermo Fisher Scientific's score of 1.10 indicating that Harvard Bioscience is being referred to more favorably in the media.

Company	Overall Sentiment
Harvard Bioscience	Very Positive
Thermo Fisher Scientific	Positive

Which has more volatility & risk, HBIO or TMO?

Harvard Bioscience has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 12 of the 16 factors compared between the two stocks.